RSPO3 is important for trabecular bone and fracture risk in mice and humans.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
13 08 2021
Historique:
received: 21 01 2021
accepted: 19 07 2021
entrez: 14 8 2021
pubmed: 15 8 2021
medline: 31 8 2021
Statut: epublish

Résumé

With increasing age of the population, countries across the globe are facing a substantial increase in osteoporotic fractures. Genetic association signals for fractures have been reported at the RSPO3 locus, but the causal gene and the underlying mechanism are unknown. Here we show that the fracture reducing allele at the RSPO3 locus associate with increased RSPO3 expression both at the mRNA and protein levels, increased trabecular bone mineral density and reduced risk mainly of distal forearm fractures in humans. We also demonstrate that RSPO3 is expressed in osteoprogenitor cells and osteoblasts and that osteoblast-derived RSPO3 is the principal source of RSPO3 in bone and an important regulator of vertebral trabecular bone mass and bone strength in adult mice. Mechanistic studies revealed that RSPO3 in a cell-autonomous manner increases osteoblast proliferation and differentiation. In conclusion, RSPO3 regulates vertebral trabecular bone mass and bone strength in mice and fracture risk in humans.

Identifiants

pubmed: 34389713
doi: 10.1038/s41467-021-25124-2
pii: 10.1038/s41467-021-25124-2
pmc: PMC8363747
doi:

Substances chimiques

R-spondin3 protein, mouse 0
RSPO3 protein, human 0
Thrombospondins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4923

Subventions

Organisme : CIHR
ID : 365825
Pays : Canada
Organisme : CIHR
ID : 409511
Pays : Canada
Organisme : Cancer Research UK
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s).

Références

BMJ. 2018 Aug 29;362:k3225
pubmed: 30158200
Am J Physiol Endocrinol Metab. 2018 Jun 1;314(6):E597-E604
pubmed: 29406783
Cell Signal. 2016 Aug;28(8):989-1000
pubmed: 27140682
Nat Commun. 2020 Jan 16;11(1):332
pubmed: 31949165
Hum Mol Genet. 2017 Jul 15;26(14):2791-2802
pubmed: 28472463
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):E2197-204
pubmed: 22745162
Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3324-9
pubmed: 15728361
PLoS Genet. 2012 Jul;8(7):e1002745
pubmed: 22792071
PLoS Genet. 2011 Apr;7(4):e1001372
pubmed: 21533022
J Bone Miner Res. 2005 Jan;20(1):67-74
pubmed: 15619671
J Clin Endocrinol Metab. 2012 Feb;97(2):311-25
pubmed: 22238383
Development. 2009 Aug;136(16):2747-56
pubmed: 19605502
Nat Genet. 2012 Apr 15;44(5):491-501
pubmed: 22504420
Genesis. 2012 Oct;50(10):741-9
pubmed: 22610508
Nature. 2012 Aug 30;488(7413):665-9
pubmed: 22895187
Nat Genet. 2015 Mar;47(3):284-90
pubmed: 25642633
Nat Med. 2013 Jan;19(1):35-42
pubmed: 23296015
Nat Commun. 2013;4:2787
pubmed: 24225776
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5474-9
pubmed: 10805804
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2294-9
pubmed: 23345419
J Endocrinol. 2007 Dec;195(3):415-27
pubmed: 18000304
J Biol Chem. 2015 Dec 11;290(50):29692-4
pubmed: 26657753
Growth Factors. 2012 Apr;30(2):117-23
pubmed: 22292523
Curr Top Dev Biol. 2010;93:189-227
pubmed: 20959167
PLoS Genet. 2013;9(2):e1003247
pubmed: 23437003
Nature. 2018 Jun;558(7708):73-79
pubmed: 29875488
Nat Med. 2012 Feb 19;18(3):405-12
pubmed: 22344299
Nature. 2019 May;569(7755):222-228
pubmed: 30971824
Nature. 2011 Jul 04;476(7360):293-7
pubmed: 21727895
J Bone Miner Res. 2010 Oct;25(10):2138-47
pubmed: 20499361
Nature. 2013 May 23;497(7450):517-20
pubmed: 23644456
Cell Metab. 2010 Jun 9;11(6):517-31
pubmed: 20519123
Nat Genet. 2020 Oct;52(10):1122-1131
pubmed: 32895551
J Bone Miner Res. 2013 Jan;28(1):2-17
pubmed: 23197339
Bone Res. 2019 Jan 8;7:2
pubmed: 30622831
J Endocrinol. 2018 May;237(2):113-122
pubmed: 29530924
Nature. 2012 Apr 29;485(7397):195-200
pubmed: 22575959
J Bone Miner Res. 2000 Aug;15(8):1477-88
pubmed: 10934646
Endocrinology. 2015 Mar;156(3):1023-32
pubmed: 25521583
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11452-7
pubmed: 21693646
J Biol Chem. 2007 May 25;282(21):15903-11
pubmed: 17400545
Sci Rep. 2017 Feb 21;7:42841
pubmed: 28220828
PLoS Genet. 2014 May 15;10(5):e1004383
pubmed: 24830394
Cell Calcium. 2005 Sep-Oct;38(3-4):439-46
pubmed: 16099039
J Clin Invest. 1999 Oct;104(7):895-901
pubmed: 10510330
Hum Mol Genet. 2014 Jun 1;23(11):3054-68
pubmed: 24430505
Nat Med. 2014 Nov;20(11):1279-88
pubmed: 25306233
Ann Hum Genet. 2018 May;82(3):143-149
pubmed: 29230809
Dev Biol. 2002 Apr 15;244(2):305-18
pubmed: 11944939
Osteoporos Int. 2005 Mar;16 Suppl 2:S3-7
pubmed: 15365697
Bone Res. 2018 Aug 14;6:24
pubmed: 30131881
Cold Spring Harb Perspect Biol. 2009 Aug;1(2):a002881
pubmed: 20066091
Genes Dev. 2013 Jun 15;27(12):1345-50
pubmed: 23756651
Nat Med. 2013 Feb;19(2):179-92
pubmed: 23389618
Dev Biol. 2007 Jan 1;301(1):218-26
pubmed: 16963017
FASEB J. 2019 Oct;33(10):11163-11179
pubmed: 31307226
Arthritis Rheum. 2010 Aug;62(8):2303-12
pubmed: 20506554
Science. 2018 Aug 24;361(6404):769-773
pubmed: 30072576
J Bone Miner Res. 2017 Jul;32(7):1395-1405
pubmed: 28177141
Dev Biol. 2018 Sep 1;441(1):42-51
pubmed: 29859889
J Intern Med. 2015 Jun;277(6):630-49
pubmed: 25845559
Development. 2018 Jun 26;145(12):
pubmed: 29945986
Nat Commun. 2020 Jun 3;11(1):2797
pubmed: 32493999
Nature. 2018 May;557(7706):564-569
pubmed: 29769720
J Dent Res. 2007 Apr;86(4):320-5
pubmed: 17384025
PLoS One. 2013 May 10;8(5):e63323
pubmed: 23675479
Commun Biol. 2020 Sep 30;3(1):543
pubmed: 32999390
Nat Commun. 2016 Jan 06;7:10129
pubmed: 26733130
EMBO Rep. 2011 Sep 30;12(10):1055-61
pubmed: 21909076
Development. 2014 Aug;141(15):2959-71
pubmed: 25053429
Bone. 2013 Jan;52(1):83-92
pubmed: 23017661
Lancet. 2012 Mar 31;379(9822):1173-4
pubmed: 22463865
Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14972-7
pubmed: 26627248
Arch Intern Med. 2005 Sep 12;165(16):1825-30
pubmed: 16157825
Nat Genet. 2019 Feb;51(2):258-266
pubmed: 30598549
Nat Med. 2014 Sep;20(9):1009-17
pubmed: 25108526

Auteurs

Karin H Nilsson (KH)

Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Petra Henning (P)

Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Maha El Shahawy (M)

Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Faculty of Dentistry, Department of Oral Biology, Minia University, Minia, Egypt.

Maria Nethander (M)

Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Thomas Levin Andersen (TL)

Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Department of Pathology, Odense University Hospital, Odense, Denmark.

Charlotte Ejersted (C)

Department of Endocrinology, Odense University Hospital, Odense, Denmark.

Jianyao Wu (J)

Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Karin L Gustafsson (KL)

Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Antti Koskela (A)

Department of Anatomy and Cell Biology, Faculty of Medicine, Institute of Cancer Research and Translational Medicine, University of Oulu, Oulu, Finland.

Juha Tuukkanen (J)

Department of Anatomy and Cell Biology, Faculty of Medicine, Institute of Cancer Research and Translational Medicine, University of Oulu, Oulu, Finland.

Pedro P C Souza (PPC)

Innovation in Biomaterials Laboratory, Faculty of Dentistry, Federal University of Goiás, Goiâna, Brazil.

Jan Tuckermann (J)

Institute of Comparative Molecular Endocrinology (CME), University of Ulm, Ulm, Germany.

Mattias Lorentzon (M)

Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Region Västra Götaland, Department of Geriatric Medicine, Sahlgrenska University Hospital, Mölndal, Sweden.
Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC, Australia.

Linda Engström Ruud (LE)

Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

Terho Lehtimäki (T)

Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland.
Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Jon H Tobias (JH)

Musculoskeletal Research Unit, Translational Health Sciences, and Medical Research Council Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK.

Sirui Zhou (S)

Department of Medicine, Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, QC, Canada.
Department of Human Genetics, McGill University, Montréal, QC, Canada.

Ulf H Lerner (UH)

Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

J Brent Richards (JB)

Department of Medicine, Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, QC, Canada.
Department of Human Genetics, McGill University, Montréal, QC, Canada.

Sofia Movérare-Skrtic (S)

Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. sofia.skrtic@gu.se.

Claes Ohlsson (C)

Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. claes.ohlsson@medic.gu.se.
Region Västra Götaland, Department of Drug Treatment, Sahlgrenska University Hospital, Gothenburg, Sweden. claes.ohlsson@medic.gu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH